Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis Yao
Neil Mehta

Showing results (1-10 of 312) with videos related to

Pageof 32
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 17, 2013
Reply: To PMID 23333661Francis Yao, Neil Mehta
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2021
DCP and AFP-L3 Are Complementary to AFP in Predicting High-Risk Explant Features: Results of a Prospective StudyPrashant Kotwani, Wesley Chan, Francis Yao, et al.
JAMA Network Open|August 31, 2019
Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical InsuranceLiat Gutin, Francis Yao, Jennifer L Dodge, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 20, 2021
Lower Alpha-Fetoprotein Threshold of 500 ng/mL for Liver Transplantation May Improve Posttransplant Outcomes in Patients With Hepatocellular CarcinomaMax L Goldman, Kali Zhou, Jennifer L Dodge, et al.
Hepatology (Baltimore, Md.)|February 20, 2019
Are There Upper Limits in Tumor Burden for Down-Staging of Hepatocellular Carcinoma to Liver Transplant? Analysis of the All-Comers ProtocolJasmine Sinha, Neil Mehta, Jennifer L Dodge, et al.
Transplantation|December 16, 2020
Sex-based Disparities in Hepatocellular Carcinoma Recurrence After Liver TransplantationGiuseppe Cullaro, Jessica Rubin, Neil Mehta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 6, 2021
National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United StatesAllison J Kwong, T Tara Ghaziani, Francis Yao, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 22, 2014
Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolizationAparna Goel, Neil Mehta, Jennifer Guy, et al.
Annals of Hepatology|May 29, 2016
Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplantMonika Sarkar, Jennifer L Dodge, John P Roberts, et al.
Journal of Hepatology|September 8, 2023
AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantationJoshua S Norman, P Jonathan Li, Prashant Kotwani, et al.
Pageof 32

Showing results (1-10 of 312) with videos related to

Sort By:
Pageof 32
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 17, 2013
Reply: To PMID 23333661Francis Yao, Neil Mehta
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2021
DCP and AFP-L3 Are Complementary to AFP in Predicting High-Risk Explant Features: Results of a Prospective StudyPrashant Kotwani, Wesley Chan, Francis Yao, et al.
JAMA Network Open|August 31, 2019
Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical InsuranceLiat Gutin, Francis Yao, Jennifer L Dodge, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 20, 2021
Lower Alpha-Fetoprotein Threshold of 500 ng/mL for Liver Transplantation May Improve Posttransplant Outcomes in Patients With Hepatocellular CarcinomaMax L Goldman, Kali Zhou, Jennifer L Dodge, et al.
Hepatology (Baltimore, Md.)|February 20, 2019
Are There Upper Limits in Tumor Burden for Down-Staging of Hepatocellular Carcinoma to Liver Transplant? Analysis of the All-Comers ProtocolJasmine Sinha, Neil Mehta, Jennifer L Dodge, et al.
Transplantation|December 16, 2020
Sex-based Disparities in Hepatocellular Carcinoma Recurrence After Liver TransplantationGiuseppe Cullaro, Jessica Rubin, Neil Mehta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 6, 2021
National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United StatesAllison J Kwong, T Tara Ghaziani, Francis Yao, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 22, 2014
Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolizationAparna Goel, Neil Mehta, Jennifer Guy, et al.
Annals of Hepatology|May 29, 2016
Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplantMonika Sarkar, Jennifer L Dodge, John P Roberts, et al.
Journal of Hepatology|September 8, 2023
AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantationJoshua S Norman, P Jonathan Li, Prashant Kotwani, et al.
Pageof 32